<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Overview of affected genes in genetic hyperpigmentation syndromes</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Overview of affected genes in genetic hyperpigmentation syndromes</h1>
<div class="graphic"><div class="figure"><div class="ttl">Overview of affected genes in genetic hyperpigmentation syndromes</div><div class="cntnt"><table cellspacing="0"><colgroup width="30%"></colgroup><colgroup span="2" width="10%"></colgroup><colgroup span="2" width="25%"></colgroup> <tbody> <tr> <td class="subtitle1">Disease</td> <td class="subtitle1">Gene(s)</td> <td class="subtitle1">Gene locus</td> <td class="subtitle1">Gene function</td> <td class="subtitle1">Caused defect</td> </tr> <tr> <td class="subtitle2_left" colspan="5">Genes involved in early melanocyte development and function</td> </tr> <tr> <td class="indent1">Dyschromatosis symmetrica hereditaria (DSH, OMIM #127400)</td> <td class="centered"><em>ADAR</em></td> <td class="centered">1q21.3</td> <td>Catalyzing the deamination of adenosine to inosine in dsRNA substrates</td> <td>Failure of correct RNA editing during melanoblast migration: Irregular distribution of hyper- or hypoactive melanocytes in the skin</td> </tr> <tr> <td class="indent1">Incontinentia pigmenti (IP, OMIM #308300)</td> <td class="centered"><em>NEMO</em></td> <td class="centered">Xq28</td> <td>Essential for NF-ΚB activation</td> <td>Mutations or deletions: Abnormal self-destruction (apoptosis) of MCs</td> </tr> <tr class="divider_bottom"> <td class="indent1">Neurofibromatosis type I (NF1, OMIM #162200)</td> <td class="centered"><em>NF1</em></td> <td class="centered">17q11.2</td> <td>Gene involved in melanosome localization</td> <td>Disruption of NF1-dynein heavy chain 1 interaction: Increased trafficking of melanosomes in melanocytes of café-au-lait macules</td> </tr> <tr> <td class="subtitle2_left" colspan="5">Genes involved in pigmentation and related pathways</td> </tr> <tr> <td class="indent1">Familial progressive hyperpigmentation (FPH, OMIM #145250)</td> <td class="centered"><em>KITLG</em></td> <td class="centered">12q22</td> <td>Melanogenesis</td> <td>Gain-of-function mutations: Increased TYR activity</td> </tr> <tr> <td class="indent1">Carney complex (CNC1, OMIM #160980)</td> <td class="centered"><em>PRKAR1A</em></td> <td class="centered">17q24.2</td> <td>Crucial signaling factor in cAMP pathway</td> <td>Mutated <em>PRKAR1A</em>: Increased cAMP activity</td> </tr> <tr class="divider_bottom"> <td class="indent1">McCune-Albright syndrome (MAS, OMIM #174800)</td> <td class="centered"><em>GNAS1</em></td> <td class="centered">20q13.32</td> <td>alpha-subunit of Gs protein (GTPase)</td> <td>Gain-of-function mutations: Increased cAMP activity</td> </tr> <tr> <td class="subtitle2_left" colspan="5">Deregulation of the tyrosinase gene</td> </tr> <tr> <td class="indent1" colspan="5">Fanconi's anemia</td> </tr> <tr> <td class="indent2">(FANCA, OMIM #227650)</td> <td class="centered"><em>FANCA</em></td> <td class="centered">16q24.3</td> <td class="divider_bottom" rowspan="6">DNA repair maintenance of chromosomal integrity</td> <td class="divider_bottom" rowspan="6">Overactivation of TYR activity due to reduced thioredoxin levels</td> </tr> <tr> <td class="indent2">(FANCB, OMIM #300514)</td> <td class="centered"><em>FANCB</em></td> <td class="centered">Xp22.2</td> </tr> <tr> <td class="indent2">(FANCC, OMIM #227645)</td> <td class="centered"><em>FANCC</em></td> <td class="centered">9q22.32</td> </tr> <tr> <td class="indent2">(FANCD1, OMIM #605724)</td> <td class="centered"><em>BRCA2</em></td> <td class="centered">13q13.1</td> </tr> <tr> <td class="indent2">(FANCD2, OMIM #227646)</td> <td class="centered"><em>FANCD2</em></td> <td class="centered">3p25.3</td> </tr> <tr class="divider_bottom"> <td class="indent2">(FANCE, OMIM #600901)</td> <td class="centered"><em>FANCE</em></td> <td class="centered">6p21.31</td> </tr> <tr> <td class="subtitle2_left" colspan="5">Genes involved in cell structure and metabolism</td> </tr> <tr> <td class="indent1">Naegeli-Franceschetti-Jadassohn syndrome (NFJ, OMIM #161000)</td> <td class="centered"><em>KRT14</em></td> <td class="centered">17q21.2</td> <td>Melanosome uptake in keratinocytes</td> <td>Abnormal melanin distribution in keratinocytes</td> </tr> <tr> <td class="indent1">Dowling-Degos syndrome (DGS, OMIM #179850)</td> <td class="centered"><em>KRT5</em></td> <td class="centered">12q13.13</td> <td>Melanosome uptake in keratinocytes; organelle transport</td> <td>Deficient melanin aggregation in keratinocytes</td> </tr> <tr> <td class="indent1">Peutz-Jeghers syndrome (PJS, OMIN #175200)</td> <td class="centered"><em>STK11</em></td> <td class="centered">19p13.3</td> <td>Serine/threonine kinase regulates cell polarity and tumor suppressor function</td> <td>Dysregulation of mTOR pathway; dysregulation of Wnt pathway</td> </tr> <tr class="divider_bottom"> <td class="indent1">LEOPARD syndrome (LS, OMIM #151100)</td> <td class="centered"><em>PTPN11</em></td> <td class="centered">12q24.13</td> <td>Tyrosine phosphatase</td> <td>Dysregulation of mTOR pathway; increased RAS activity</td> </tr> <tr> <td class="subtitle2_left" colspan="5">Genes involved in DNA repair or senescence</td> </tr> <tr> <td class="indent1" colspan="5">Xeroderma pigmentosum</td> </tr> <tr> <td class="indent2">(XPA, OMIM #278700)</td> <td class="centered"><em>XPA</em></td> <td class="centered">9q22.33</td> <td rowspan="7">DNA repair gene</td> <td rowspan="7">Failure of nucleotide excision repair machinery</td> </tr> <tr> <td class="indent2">(XPB, OMIM #610651)</td> <td class="centered"><em>ERCC3</em></td> <td class="centered">2q14.3</td> </tr> <tr> <td class="indent2">(XPC, OMIM #278720)</td> <td class="centered"><em>XPC</em></td> <td class="centered">3p25.1</td> </tr> <tr> <td class="indent2">(XPD, OMIM #278730)</td> <td class="centered"><em>ERCC2</em></td> <td class="centered">19q13.32</td> </tr> <tr> <td class="indent2">(XPE, OMIM #278740)</td> <td class="centered"><em>DDB2</em></td> <td class="centered">11p11.2</td> </tr> <tr> <td class="indent2">(XPF, OMIM #278760)</td> <td class="centered"><em>ERCC4</em></td> <td class="centered">16p13.12</td> </tr> <tr> <td class="indent2">(XPG, OMIM #278780)</td> <td class="centered"><em>ERCC5</em></td> <td class="centered">13q33.1</td> </tr> <tr> <td class="indent1" colspan="5">Dyskeratosis congenita</td> </tr> <tr> <td class="indent2">(DKCX, OMIM #305000)</td> <td class="centered"><em>DKC1</em></td> <td class="centered">Xq28</td> <td rowspan="3">Components of the telomerase complex</td> <td rowspan="3">Accumulation of DNA damage increased melanin synthesis in senescent melanocytes</td> </tr> <tr> <td class="indent2">(DKCA1, OMIM #127550)</td> <td class="centered"><em>TERC</em></td> <td class="centered">3q26.2</td> </tr> <tr> <td class="indent2">(DKCA2, OMIM #613989)</td> <td class="centered"><em>TERT</em></td> <td class="centered">5p15.3</td> </tr> </tbody></table></div><div class="graphic_footnotes">LEOPARD: lentigines, electrocardiogram abnormalities, ocular hypertelorism, pulmonic stenosis, abnormal genitalia, retardation of growth, deafness.</div><div class="graphic_reference">From: Speeckaert R, Van Gele M, Speeckaert MM, et al. The biology of hyperpigmentation syndromes. Pigment Cell Melanoma Res 2014; 27:512. <a href="http://onlinelibrary.wiley.com/wol1/doi/10.1111/pcmr.12235/abstract" target="_blank">http://onlinelibrary.wiley.com/wol1/doi/10.1111/pcmr.12235/abstract</a>. Copyright © 2014 John Wiley &amp; Sons A/S. Reproduced with permission of John Wiley &amp; Sons Inc. This image has been provided by or is owned by Wiley. Further permission is needed before it can be downloaded to PowerPoint, printed, shared or emailed. Please contact Wiley's permissions department either via email: <a href="/cdn-cgi/l/email-protection#5c2c392e31352f2f3533322f1c2b35303925723f3331" target="_blank"><span class="__cf_email__" data-cfemail="b6c6d3c4dbdfc5c5dfd9d8c5f6c1dfdad3cf98d5d9db">[email protected]</span></a> or use the RightsLink service by clicking on the 'Request Permission' link accompanying this article on Wiley Online Library (<a href="http://onlinelibrary.wiley.com" target="_blank">http://onlinelibrary.wiley.com</a>).</div><div id="graphicVersion">Graphic 112464 Version 1.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
